PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancer.
Science Translational Medicine.
Times cited: 122
Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients.
Proceedings of the National Academy of Sciences of the United States of America.
Times cited: 177